Collegium Pharmaceutical (COLL) PT Lowered to $27 at Truist Securities
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $22.63 +0.80%
Rating Summary:
10 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 13 | New: 54
Rating Summary:
10 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 13 | New: 54
Join SI Premium – FREE
Truist Securities analyst Gregg Gilbert lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $27.00 (from $28.00) while maintaining a Buy rating.
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
- Cal-Maine Foods (CALM) PT Lowered to $75 at BMO Capital
- TransUnion (TRU) PT Lowered to $80 at UBS as CFO Transition Announced
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
